Board Chair Maria Rankka has today notified the Board of Directors that she will step down as Board Chair and board member of BICO Group AB (publ) effective 31 July 2026. Board members Susanne Lithander and Johan Westman have also informed the Board that they will leave their Board assignments at the same time.
The Board of Directors will therefore resolve to convene an Extraordinary General Meeting to elect new board members.
Comment from Maria Rankka:
“After careful consideration, I have concluded that the Board Chair assignment has developed in a direction that differs from the assignment I originally accepted. I believe the company is best served by a chairmanship fully aligned with its continued growth journey and the expectations of larger shareholders. I will do my utmost to support a constructive and orderly transition.”
Notice of the Extraordinary General Meeting will be published separately in accordance with applicable regulations.
For further information, please contact:
Maria Forss, President & CEO, BICO Group AB
Phone: EA Elisabeth Lindell +46 761 73 40 59
E-mail:
Ewa Linsäter, Chief Financial Officer, BICO Group AB
Phone: +46 766 33 32 33
E-mail:
About BICO
BICO leverages a global portfolio of pioneering brands fusing automation, intelligence, and data to unlock scientific discovery at scale in pharma and biotech. With 53,600+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 13,000 publications. BICO strives towards the vision to enable life-science labs to accelerate the discoveries that change lives. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com
This information is information that BICO Group is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-07-06 12:06 CEST.
Attachments